New Informative Study on Psychedelic Drugs Market 2021-2027 | Evolving Players – Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd

Psychedelic Drugs Market

The Psychedelic Drugs Market is expected to gain market growth in the forecast period of 2021 to 2027. MarketDigits analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2021 to 2028 and is expected to reach USD 7,567.52 million by 2027 from USD XX million in 2020. At present, the market is sharping its presence and some of the key players in the study are The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, and ALLERGAN.

To understand how our report can bring difference to your business strategy, Ask for a brochure @

Global Market Analysis and Insights: Global Psychedelic Drugs Market

The rising prevalence of mental depression and anxiety and availability of off-label drugs are the major drivers which has propelled the demand of the psychedelic drugs market in the forecast period.

Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychedelic drugs have the ability to change or enhance the senosory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences. Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD.

The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures and professionals which is increasing the demand of psychedelic drugs and the rising awareness towards mental health is acting as a driver for the psychedelic drugs market. Changes in the regulation charges for psychedelic drugs approval and taking regulatory approval could lead to delay product launch and stringent regulatory is working as a restraint for the psychedelic drugs market. Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the psychedelic drugs market, thus increasing R&D activities in psychedelic drugs is acting as an opportunity for the growth of the psychedelic drugs market. The increasing side effects of the psychedelic drugs act as a challenge for the growth of the psychedelic drugs market in the forecasted period.

Grab Complete Details with TOC @

The psychedelic drugs market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the psychedelic drugs market scenario contact MarketDigits for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Psychedelic Drugs Market Scope and Market Size

The psychedelic drugs market is segmented into seven notable segments which are based on the source, type, drugs, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of source, the psychedelic drugs market is segmented into synthetic and natural. In 2021, synthetic segment is dominating as most of the products are made from chemicals that are man-made with very few products such as psilocybin made from natural ingredients.
  • On the basis of type, the psychedelic drugs market is segmented into dissociatives, empathogens and others. In 2021, empathogens segment produce experiences of emotional communion, oneness, relatedness and used for treatment of cataplexy, narcolepsy and related disorders.
  • On the basis of drugs, the psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. In 2021, gamma-hydroxybutyric acid segment is dominating as xyrem from Jazz Pharmaceutical is one of the oldest available psychedelic drugs available in the market holding a major share and belongs to the drug class.
  • On the basis of application, the psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, post-traumatic stress disorder, major depressive disorder, opiate addiction and others. In 2021, narcolepsy segment is dominating as xyrem from Jazz Pharmaceutical is used for its treatment and it is the major shareholder in the market.
  • On the basis of route of administration, the psychedelic drugs market is segmented into oral, inhalation and injectable. In 2021, oral segment is dominating as it is preferred over the various other administration routes of drug delivery.
  • On the basis of end user, the psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. In 2021, hospitals segment dominate the psychedelic drugs market due to the high patient load and most of the drugs are given under doctor’s supervision.
  • On the basis of distribution channel, the psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy. In 2021, hospitals pharmacy segment holds the largest market share as more number of patients is treated in hospitals and the demand for medicines in hospital pharmacy increases.

Global Psychedelic Drugs Market Country Level Analysis

The psychedelic drugs market is analysed and market size information is based on the country, source, type, drugs, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the psychedelic drugs market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, rest of Europe, Saudi Arabia, UAE, Israel and Egypt.

In North America, the U.S. is dominating the market due to growing acceptance of psychedelic drugs for treating depression and rise in product approvals. However, In Europe, Germany is dominating the market due to rising awareness towards mental health. Whereas, Saudi Arabia is dominating in Middle East and Africa due to ongoing clinical trials and increasing prevalence of depression and mental disorders in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Psychedelic Drugs Market

The psychedelic drugs market also provides you with detailed market analysis for every country growth in aesthetic industry with psychedelic drugs sales, impact of advancement in the psychedelic drugs and changes in regulatory scenarios with their support for the psychedelic drugs market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Global Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus.

The major companies providing psychedelic drugs are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals, Inc., PharmaTher Inc., Avadel, Celon Pharma S.A., NeuroRx, Inc., among other domestic players. MarketDigits analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the global psychedelic drugs market.

For instance,

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray for treatment of suicidal people. As per the data published, approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide. Hence, this approval provided these patients with a remarkable therapy and allowed company to generate more revenue.
  • In January 2020, Jazz Pharmaceuticals, Inc. has received the marketing authorization of solriamfetol (Sunosi) indicated for treatment of excessive daytime sleepiness in adults with narcolepsy. This authorization allowed the company to enhance product distribution network and to generate more revenue in the market.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the psychedelic drugs market which also provides the benefit for organisation to improve their offering for psychedelic drugs.

Businesses can depend with confidence upon this superior Psychedelic Drugs market report to bring about an utter success. An expert team involved in creating this report concentrates on understanding client’s businesses & its needs so that the deluxe Psychedelic Drugs market research report is delivered to the client. The company profiles of all the dominating market players & brands that are making moves such as product launches, joint ventures, mergers and acquisitions are described in the Psychedelic Drugs report. Talented capabilities & brilliant resources in research, data collection, development, consulting, evaluation, compliance & regulatory services work together to formulate this world-class Psychedelic Drugs market research report.

Detailed TOC of Psychedelic Drugs Market Research Report-
– Psychedelic Drugs Introduction and Market Overview
– Psychedelic Drugs Market, by Application [Personal & Business]
– Psychedelic Drugs Industry Chain Analysis
– Psychedelic Drugs Market, by Type [, Public Cloud, Private Cloud & Hybrid Cloud]
– Industry Manufacture, Consumption, Export, Import by Regions (2015-2020)
– Industry Value ($) by Region (2015-2020)
– Psychedelic Drugs Market Status and SWOT Analysis by Regions
– Major Region of Psychedelic Drugs Market
i) Global Psychedelic Drugs Sales
ii) Global Psychedelic Drugs Revenue & market share
– Major Companies List
– Conclusion

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, MINT, BRICS, G7, Western / Eastern Europe or Southeast Asia. Also, we can serve you with customize research services as MarketDigits holds a database repository that includes public organizations and Millions of Privately held companies with expertise across various Industry domains.

Any Questions? Inquire Here Before Buying @

About MarketDigits :

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us:
USA : +1 847 450 0808
Email :

Back to top button